Prioritizing LDL-C Reduction for Established CVD Patients in Primary Care
Exploring the Risk of HF Hospitalization or CV Death in HFrEF Patients and a Potential Treatment Option
Javed Butler, MD, MPH, FACC, FAHA
PeerDeep Learner: Building AI to Improve Cardiovascular Care
Pierre Elias, MD
PeerConfronting the Complexities of Reaching LDL-C Thresholds in Patients with Primary Hyperlipidemia
Michael Bloch, MD
PeerPrimary Hyperlipidemia: Fresh look at an LDL-C Therapy and its Long-Term Data
Overcoming Real World Challenges of LDL-C Management: Looking Beyond Statin Therapy
Reshaping LDL-C Management in Primary Hyperlipidemia with First-in-Class siRNA Therapy
The Pathophysiology and Pathoetiology of Heart Failure
Stephen Greene, MD
PeerThe Disease Burden and Epidemiology of Heart Failure
Nancy M. Albert, PhD, CCNS, CHFN, CCRN, NE-BC, FAHA, FCCM, FHFSA, FAAN
PeerThe Importance of Making an Accurate and Timely Heart Failure Diagnosis
Pamela Kushner, MD, FAAFP
PeerHeart Failure Disease State Awareness
Nancy M. Albert, PhD, CCNS, CHFN, CCRN, NE-BC, FAHA, FCCM, FHFSA, FAAN
PeerGuideline Directed Medical Therapy for the Management of Heart Failure
Stephen Greene, MD
PeerThe Interconnectivity of The Cardio-Renal-Metabolic Systems and Associated Comorbidities
Pamela Kushner, MD, FAAFP
PeerCritical Considerations of Residual CV Risk in Patients With T2D & ASCVD
A Treatment for NYHA Class II-III Obstructive HCM Patients